Société Francophone de Néphrologie, Dialyse et Transplantation
The Société Francophone de Néphrologie, Dialyse et Transplantation (SFNDT) is a leading organisation in the field of nephrology, dialysis, and transplantation, headquartered in France. Established to advance the understanding and treatment of kidney diseases, SFNDT has made significant contributions to the industry since its inception. With a focus on promoting research, education, and best practices, the organisation serves a wide network across French-speaking regions, enhancing patient care and professional development. SFNDT is renowned for its commitment to innovation in renal therapies and its role in shaping clinical guidelines. Notable achievements include fostering collaboration among healthcare professionals and hosting influential conferences that address the latest advancements in nephrology. Through its core services, SFNDT continues to elevate standards in kidney health, making it a pivotal player in the medical community.
DitchCarbon Score
How does Société Francophone de Néphrologie, Dialyse et Transplantation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Société Francophone de Néphrologie, Dialyse et Transplantation's score of 30 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Société Francophone de Néphrologie, Dialyse et Transplantation's reported carbon emissions
In 2022, Société Francophone de Néphrologie, Dialyse et Transplantation (SFNDT) reported total carbon emissions of approximately 10,336 kg CO2e. This figure includes 8,900 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 1,436 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Notably, there were no reported Scope 3 emissions. Despite the emissions data, SFNDT has not established specific reduction targets or initiatives as part of their climate commitments. The organisation's focus appears to be on understanding and reporting their carbon footprint rather than implementing formal reduction strategies at this time. Overall, SFNDT's emissions reflect the ongoing challenges faced by healthcare organisations in managing their environmental impact, particularly in the context of patient care and operational activities.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | |
|---|---|
| Scope 1 | 8,900 |
| Scope 2 | 1,436 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Société Francophone de Néphrologie, Dialyse et Transplantation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
